Digestive and Liver Diseases / Nursing

Overview

The Digestive & Liver Diseases / Nursing research area is composed by three groups, whose main goal is to develop basic and traslational studies on the most frequent and impacting digestive and liver disorders afflicting the general population. In particular, the group of Physiology and Pathophysiology of the Digestive Tract integrates investigations on the function of the gastrointestinal tract including secretion, motility and absorption with cellular, molecular, immune and genetic aspects and their interactions with the microbiota and the brain-gut axis. The Liver Diseases Group deals clinical and basic research in viral hepatitis, liver cirrhosis, liver cancer and also non-alcoholic fatty liver disease and their complications. Finally, our area includes the Multidisciplinar Nursing research group which aims to generate knowledge in the specific area of activity of nurses and collaborate with other health professionals to improve care given to patients.

Publications

129

total

952

impact factor

7.38

average impact factor

Group Leader: Joan Genescà Ferrer

team

group-zoom

zoom

group-download

download

During 2020, we have continued our internationalization in terms of grants, publications, participation in different consortia, and most importantly our involvement in the design of clinical guidelines for liver diseases in Europe and involvement in European Institutions for Liver Diseases. It is worth to mention the coordination of our group of an IMI project from H2020, in addition to participating in 6 additional H2020 projects.

85

total

765

impact factor

9^.00

average impact factor

SELECTED ARTICLES

Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernandez J, Prati D, Baselli G, Asselta R, Grimsrud MM, Milani C, Aziz F, Kassens J, May S, Wendorff M, Wienbrandt L, Uellendahl-Werth F, Zheng T, Yi X, de Pablo R, Chercoles AG, Palom A, Garcia-Fernandez AE, Rodriguez-Frias F, Zanella A, Bandera A, Protti A, Aghemo A, Lleo A, Biondi A, Caballero-Garralda A, Gori A, Tanck A, Carreras Nolla A, Latiano A, Fracanzani AL, Peschuck A, Julia A, Pesenti A, Voza A, Jimenez D, Mateos B, Nafria Jimenez B, Quereda C, Paccapelo C, Gassner C, Angelini C, Cea C, Solier A, Pestana D, Muniz-Diaz E, Sandoval E, Paraboschi EM, Navas E, Garcia Sanchez F, Ceriotti F, Martinelli-Boneschi , Peyvandi F, Blasi F, Tellez L, Blanco-Grau A, Hemmrich-Stanisak G, Grasselli G, Costantino G, Cardamone G, Foti G, Aneli S, Kurihara H, ElAbd H, My I, Galvan-Femenia I, Martin J, Erdmann J, Ferrusquia-Acosta J, Garcia-Etxebarria K, Izquierdo-Sanchez L, Bettini LR, Sumoy L, Terranova L, Moreira L, Santoro L, Scudeller L, Mesonero F, Roade L, Ruhlemann MC, Schaefer M, Carrabba M, Riveiro-Barciela M, Figuera Basso ME, Valsecchi MG, Hernandez-Tejero M, Acosta-Herrera M, D’Angio M, Baldini M, Cazzaniga M, Schulzky M, Cecconi M, Wittig M, Ciccarelli M, Rodriguez-Gandia M, Bocciolone M, Miozzo M, Montano N, Braun N, Sacchi N, Martinez N, Ozer O, Palmieri O, Faverio P, Preatoni P, Bonfanti P, Omodei P, Tentorio P, Castro P, Rodrigues PM, Blandino Ortiz A, de Cid R, Ferrer R, Gualtierotti R, Nieto R, Goerg S, Badalamenti S, Marsal S, Matullo G, Pelusi S, Juzenas S, Aliberti S, Monzani V, Moreno V, Wesse T, Lenz TL, Pumarola T, Rimoldi V, Bosari S, Albrecht W, Peter W, Romero-Gomez M, D’Amato M, Duga S, Banales JM, Hov JR, Folseraas T, Valenti L, Franke A, Karlsen TH.
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
N Engl J Med. 2020 Oct 15;383(16):1522-1534. Epub 2020 Jun 17.
DOI: 10.1056/NEJMoa2020283
IF: 74.70
Montal R, Sia D, Montironi C, Leow WQ, Esteban-Fabró R, Pinyol R, Torres-Martin M, Bassaganyas L, Moeini A, Peix J, Cabellos L, Maeda M, Villacorta-Martin C, Tabrizian P, Rodriguez-Carunchio L, Castellano G, Sempoux C, Minguez B, Pawlik TM, Labgaa I, Roberts LR, Sole M, Fiel MI, Thung S, Fuster J, Roayaie S, Villanueva A, Schwartz M, Llovet JM.
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
J Hepatol. 2020 Aug;73(2):315-327. Epub 2020 Mar 12.
DOI: 10.1016/j.jhep.2020.03.008
IF: 20.58
Chu H, Duan Y, Lang S, Jiang L, Wang Y, Llorente C, Liu J, Mogavero S, Bosques-Padilla F, Abraldes JG, Vargas V, Tu XM, Yang L, Hou X, Hube B, Stärkel P, Schnabl B.
The Candida albicans exotoxin Candidalysin promotes alcohol-associated liver disease.
J Hepatol. 2020 Mar;72(3):391-400. Epub 2019 Oct 10.
DOI: 10.1016/j.jhep.2019.09.029
IF: 20.58
Pons M, Rodríguez-Tajes S, Esteban JI, Mariño Z, Vargas V, Lens S, Buti M, Augustin S, Forns X, Mínguez B, Genescà J.
Non-invasive prediction of liver related events in HCV compensated Advanced chronic liver disease patients after oral antivirals.
J Hepatol. 2020 Mar;72(3):472-480. Epub 2019 Oct 17.
DOI: 10.1016/j.jhep.2019.10.005
IF: 20.58
Brown RS Jr, Buti M, Rodrigues L, Chulanov V, Chuang WL, Aguilar H, Horváth G, Zuckerman E, Carrion BR, Rodriguez-Perez F, Urbánek P, Abergel A, Cohen E, Lovell SS, Schnell G, Lin CW, Zha J, Wang S, Trinh R, Mensa FJ, Burroughs M, Felizarta F.
Glecaprevir/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1-6 and compensated cirrhosis: the EXPEDITION-8 trial.
J Hepatol. 2020 Mar;72(3):441-449. Epub 2019 Nov 2.
DOI: 10.1016/j.jhep.2019.10.020
IF: 20.58

View all publications